Society for Endocrinology - a world-leading authority on hormones
Search
Members' area
About Us
Press
Corporate
Contact
Members' area
Toggle navigation
News
Events
Publications
Grants and Awards
Membership
Careers
Clinical practice
Outreach
About Us
Press
Corporate
Contact
Events
Home
Events
SfE BES Conference
SfE BES 2019
Scientific programme
Scientific programme
Full Programme
Days
Speakers
Posters
Focus area
Session type
Search
11 November 2019
12 November 2019
13 November 2019
Days
Speakers
Posters
Focus area
Session type
Bookmarks
15:50
Auditorium 2
Session starts at 15:05
OC1.4
OC1.4
5β-reductase (AKR1D1) is downregulated in patients with non-alcoholic fatty liver disease and protects against hepatocellular carcinoma cell proliferation in vitro.
Nikolaos Nikolaou
(University of Oxford, United Kingdom)
P171
5β-reductase (AKR1D1) isoforms differentially regulate natural and synthetic glucocorticoid clearance and glucocorticoid receptor activation in vitro.
Nathan Appanna, Anastasia Arvaniti, Elena Gangitano, Karen Morris, Sherly George, Brian Keevil, Jeremy Tomlinson, Nikolaos Nikolaou
P186
AKR1D1 (5β-reductase) deletion drives hepatic inflammation, fibrosis and tumour development in vivo.
Shelley Harris, Nikolaos Nikolaou, Anastasia Arvaniti, Roger Cox, Laura Gathercole, Jeremy Tomlinson
×